Skip to main content
SpringerLink
Log in

Clinical utility of myocardial fatty acid imaging in patients with end-stage renal disease

  • Review Article
  • Published:
Journal of Nuclear Cardiology Aims and scope

Abstract

The prevalence of coronary artery disease (CAD) appears to be much higher in patients with end-stage renal disease (ESRD) undergoing dialysis than in a non-ESRD population. Cardiac death due to myocardial ischemia significantly contributes to the high mortality rate of ESRD patients. However, the method for screening for CAD in ESRD patients has not been established, because the frequency of silent myocardial ischemia is high and examinations requiring stress are often difficult to perform among this population. Myocardial fatty acid imaging may be a new modality to detect myocardial ischemia and identify the group at high risk for cardiac death among ESRD patients without adding any stress.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Farias MA, McClellan W, Soucie JM, Mitch WE. A prospective comparison of methods for determining if cardiovascular disease is a predictor of mortality in dialysis patients. Am J Kidney Dis 1994;23:382–8.

    PubMed  CAS  Google Scholar 

  2. Parfrey PS, Foley RN. The clinical epidemiology of cardiac disease in chronic renal failure. J Am Soc Nephrol 1999;10:1606–15.

    PubMed  CAS  Google Scholar 

  3. Collins AJ, Robert F, Herzog C, Chavers B, Gilbertson D, Ishani A, et al. Cardiovascular special studies. Excerpts from United States Renal DataSystem 2006 Annual Data Report. Am J Kidney Dis 2008;51 (Suppl 1):S191–206.

    Google Scholar 

  4. An overview of regular dialysis treatment in Japan as of Dec. 31, 2004. In: Tsubakihara Y, Akiba T, Iseki K, Watanabe Y, Itami Y, Masakane I, et al, editors. Tokyo: Japanese Society for Dialysis Therapy; 2008. p. 17–20.

    Google Scholar 

  5. Kramer W, Wizemann V, Mandelbaum AP, Ritz E. Cardiovascular problems in uraemic patients. In: Cameron S, Davison AM, Grübfeld J-P, Kerr D, Ritz E, editors. Oxford textbook of clinical nephrology. Vol 2. Oxford: Oxford Medical Publications; 1992. p. 1264–78.

    Google Scholar 

  6. Manske CL, Thomas W, Wang Y, Wilson RF. Screening diabetic transplant candidates for coronary artery disease: Identification of a low risk subgroup. Kidney Int 1993;44:617–21.

    Article  PubMed  CAS  Google Scholar 

  7. Rostand SG, Rutsky EA. Ischemic heart disease in chronic renal failure: Management considerations. Semin Dial 1989;2:98–101.

    Article  Google Scholar 

  8. Joki N, Hase N, Nakamura R, Yamaguchi T. Onset of coronary artery disease prior to initiation of haemodialysis in patients with end-stage renal disease. Nephrol Dial Transplant 1997;12:718–23.

    Article  PubMed  CAS  Google Scholar 

  9. Ohtake T, Kobayashi S, Moriya H, Negishi K, Okamoto K, Maesato K, et al. High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: An angiographic examination. J Am Soc Nephrol 2005;16:1141–8.

    Article  PubMed  Google Scholar 

  10. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998;9(Suppl 12):S16–23.

    PubMed  CAS  Google Scholar 

  11. Stack AG, Bloembergen WE. Prevalence and clinical correlates of coronary artery disease among new dialysis patients in the United States: A cross-sectional study. J Am Soc Nephrol 2001;12:1516–23.

    PubMed  CAS  Google Scholar 

  12. Hajj-Ali R, Salem M, Park C. Dialysis patients undergoing percutaneous coronary interventions are at increased risk for vascular complications [abstract]. Am J Cardiol 2002;90(Suppl 6A):168H.

    Google Scholar 

  13. Dahan M, Viron BM, Faraggi M, Himbert DL, Lagallicier BJ, Kolta AM, et al. Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patients. Kidney Int 1998;54:255–62.

    Article  PubMed  CAS  Google Scholar 

  14. Dahan M, Viron BM, Poiseau E, Kolta AM, Aubry N, Paillole C, et al. Combined dipyridamole-exercise stress echocardiography for detection of myocardial ischemia in hemodialysis patients: An alternative to stress nuclear imaging. Am J Kidney Dis 2002;40:737–44.

    Article  PubMed  Google Scholar 

  15. Reis G, Marcovitz PA, Leichtman AB, Merion RM, Fay WP, Werns SW, et al. Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease. Am J Cardiol 1995;75:707–10.

    Article  PubMed  CAS  Google Scholar 

  16. Neely R, Rovetto J, Oram F. Myocardial utilization of carbohydrate and lipids. Prog Cardiovasc Dis 1972;15:289–99.

    Article  PubMed  CAS  Google Scholar 

  17. Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schönekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim Biophys Acta 1994;1213:263–76.

    PubMed  CAS  Google Scholar 

  18. Yamamichi Y, Kusuoka H, Morishita K, Shirakami Y, Kurami M, Okano K, et al. Metabolism of iodine-123-BMIPP in perfused rat hearts. J Nucl Med 1995;36:1043–50.

    PubMed  CAS  Google Scholar 

  19. Tanaka T, Okamoto F, Sohmiya K, Kawamura K. Lack of myocardial iodine-123 15-(p-iodiphenyl)-3-R, S-methylpentadecanoic acid (BMIPP) uptake and CD36 abnormality–CD36 deficiency and hypertrophic cardiomyopathy. Jpn Circ J 1997;61:724–5.

    Article  PubMed  CAS  Google Scholar 

  20. Kawasaki T, Ito K, Okano A, Nagata K, Okamoto A, Yoneyama S, et al. A dynamic change by123I-15-(p-iodophenyl)-3-R,S-methyl pentadecanoic acid myocardial single photon emission computed tomography in a 55-year-old woman. Jpn Circ J 1999;63:732–6.

    Article  PubMed  CAS  Google Scholar 

  21. Fujibayashi Y, Yonekura Y, Takemura Y, Wada K, Matsumoto K, Tamaki N, et al. Myocardial accumulation of iodinated beta-methylbranched fatty acid analogue, iodine-125-15-(p-iodophenyl)-3-(R,S) methyl pentadecanoic acid (BMIPP), in relation to ATP concentration. J Nucl Med 1990;31:1818–22.

    PubMed  CAS  Google Scholar 

  22. Fujibayashi Y, Nohara R, Hosokawa R, Okuda K, Yonekura Y, Tamaki N, et al. Metabolism and kinetics of iodine-123-BMIPP in canine myocardium. J Nucl Med 1996;37:757–61.

    PubMed  CAS  Google Scholar 

  23. Hosokawa R, Nohara R, Fujibayashi Y, Okuda K, Ogino M, Hata T, et al. Metabolic fate of iodine-123-BMIPP in canine myocardium after administration of etomoxir. J Nucl Med 1996;37:1836–40.

    PubMed  CAS  Google Scholar 

  24. Hosokawa R, Nohara R, Fujibayashi Y, Okuda K, Ogino M, Hata T, et al. Myocardial kinetics of iodine-123-BMIPP in canine myocardium after regional ischemia and reperfusion: Implications for clinical SPECT. J Nucl Med 1997;38:1857–63.

    PubMed  CAS  Google Scholar 

  25. Knapp FF Jr, Franken P, Kropp J. Cardiac SPECT with iodine-123-labeled fatty acids: Evaluation of myocardial viability with BMIPP. J Nucl Med 1995;36:1022–30.

    PubMed  CAS  Google Scholar 

  26. Tateno M, Tamaki N, Yukihiro M, Kudoh T, Hattori N, Tadamura E, et al. Assessment of fatty acid uptake in ischemic heart disease without myocardial infarction. J Nucl Med 1996;37:1981–5.

    PubMed  CAS  Google Scholar 

  27. Fujiwara S, Takeishi Y, Atsumi H, Takahashi K, Tomoike H. Fatty acid metabolic imaging with iodine-123-BMIPP for the diagnosis of coronary artery disease. J Nucl Med 1997;38:175–80.

    PubMed  CAS  Google Scholar 

  28. Takeishi Y, Fujiwara S, Atsumi H, Takahashi K, Sukekawa H, Tomoike H. Iodine-123-BMIPP imaging in unstable angina: A guide for interventional strategy. J Nucl Med 1997;38:1407–11.

    PubMed  CAS  Google Scholar 

  29. Suzuki A, Takada Y, Nagasaka M, Kato R, Watanabe T, Shimokata K, et al. Comparison of resting β-methyl-iodophenyl pentadecanoic acid (BMIPP) and thallium-201 tomography using quantitative polar maps in patients with unstable angina. Jpn Circ J 1997;61:133–8.

    Article  PubMed  CAS  Google Scholar 

  30. Misumi I, Kimura Y, Hokamura Y, Yamabe H, Ueno K. Myocardial rest iodine-123-β-methyl-iodophenyl pentadecanoic acid scintigraphy compared with dipyridamole stress thallium-201 scintigraphy in unstable angina. Intern Med 1998;37:21–6.

    Article  PubMed  CAS  Google Scholar 

  31. Yamabe H, Abe H, Yokoyama M, Shiotani H, Kajiya S, Mori T, et al. Resting123I-BMIPP scintigraphy in diagnosis of effort angina pectoris with reference to subsets of the disease. Ann Nucl Med 1998;12:139–44.

    PubMed  CAS  Google Scholar 

  32. Morimoto K, Tomoda H, Yoshitake M, Aoki N, Handa S, Suzuki Y. Prediction of coronary artery lesions in unstable angina by iodine 123 beta-methyl iodophenyl pentadecanoic acid (BMIPP), a fatty acid analogue, single photon emission computed tomography at rest. Angiology 1999;50:639–48.

    Article  PubMed  CAS  Google Scholar 

  33. Watanabe K, Ohta Y, Toba K, Ogawa Y, Aizawa Y, Tanabe N, et al. Abnormal fatty acid metabolism in patients with coronary spasm. Ann Nucl Med 1999;13:33–41.

    Article  PubMed  CAS  Google Scholar 

  34. Yamabe H, Fujiwara S, Rin K, Ando M, Yokoyama M, Sakamoro T, et al. Resting123I-BMIPP scintigraphy for detection of organic coronary stenosis and therapeutic outcome in patients with chest pain. Ann Nucl Med 2000;14:187–92.

    Article  PubMed  CAS  Google Scholar 

  35. Kawai Y, Tsukamoto E, Nazaki Y, Morita K, Sakurai M, Tamaki N. Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain. J Am Coll Cardiol 2001;38:1888–94.

    Article  PubMed  CAS  Google Scholar 

  36. Dilsizian V, Bateman TM, Bergmann SR, Des Prez R, Magram MY, Goodbody AE, et al. Metabolic imaging with b-methyl-p-[123I]-iodophenyl-pentadecanoic acid (BMIPP) identifies ischemic memory following demand ischemia. Circulation 2005;112:2169–74.

    Article  PubMed  Google Scholar 

  37. Nishimura M, Hashimoto T, Kobayashi H, Fukuda T, Okino K, Yamamoto N, et al. Myocardial scintigraphy using a fatty acid analogue detects coronary artery disease in hemodialysis patients. Kidney Int 2004;66:811–9.

    Article  PubMed  Google Scholar 

  38. Nishimura M, Murase M, Hashimoto T, Kobayashi H, Yamazaki S, Imai R, et al. Influence of diabetes mellitus on diagnostic potential of iodine-123-BMIPP imaging for coronary artery stenosis in hemodialysis patients. J Nephrol 2006;19:481–91.

    PubMed  CAS  Google Scholar 

  39. Amann K, Neusüss R, Ritz E, Irzyniec T, Wiest G, Mall G. Changes in vascular architecture independent of blood pressure in experimental uremia. Vascular hypertrophy in uremia is independent of hypertension. Am J Hypertens 1995;8:409–17.

    Article  PubMed  CAS  Google Scholar 

  40. Barenbrock M, Spieker C, Laske V, Heidenreich S, Hohage H, Bachmann J, et al. Studies of vessel wall properties in hemodialysis patients. Kidney Int 1994;45:1397–400.

    Article  PubMed  CAS  Google Scholar 

  41. Amann K, Wiest G, Zimmer G, Gretz N, Ritz E, Mall G. Reduced capillary density in the myocardium of uremic rats—a stereological study. Kidney Int 1992;42:1079–85.

    Article  PubMed  CAS  Google Scholar 

  42. Amann K, Breitbach M, Ritz E, Mall G. Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol 1998;9:1018–22.

    PubMed  CAS  Google Scholar 

  43. Nishimura M, Murase M, Hashimoto T, Kobayashi H, Yamazaki S, Imai R, et al. Insulin resistance and impaired myocardial fatty acid metabolism in dialysis patients with normal coronary arteries. Kidney Int 2006;69:553–9.

    Article  PubMed  CAS  Google Scholar 

  44. Wanner C, Hoerl WH. Carnitine abnormalities in patients with renal insufficiency. Nephron 1988;50:89–102.

    Article  PubMed  CAS  Google Scholar 

  45. Sakurabayashi T, Takaesu Y, Haginoshita S, Takeda T, Aoike I, Miyazaki S, et al. Improvement of myocardial fatty acid metabolism through L-carnitine administration to chronic hemodialysis patients. Am J Nephrol 1999;19:480–4.

    Article  PubMed  CAS  Google Scholar 

  46. Bartel LL, Hussey JL, Shrago E. Effect of dialysis on serum carnitine, free fatty acids, and triglyceride levels in man and the rat. Metabolism 1982;31:944–7.

    Article  PubMed  CAS  Google Scholar 

  47. Wessel-Aas T, Blomhoff JP, Wirum E, Nilsen T. Hemodialysis and cell toxicity in vitro related to plasma triglycerides, post-heparin lipolytic activity and free fatty acids. Acta Med Scand 1984;216:75–83.

    PubMed  CAS  Google Scholar 

  48. Nohara R, Hosokawa R, Hirai T, Okuda K, Ogino M, Fujibayashi Y, et al. Effect of metabolic substrate on BMIPP metabolism in canine myocardium. J Nucl Med 1998;39:1132–7.

    PubMed  CAS  Google Scholar 

  49. Takeishi Y, Atsumi H, Fujiwara S, Takahashi K, Tomoike H. Fatty acid metabolic imaging with 123I-BMIPP for the diagnosis of coronary artery disease: Application of patients with diabetes and hyperlipidaemia. Nucl Med Commun 1996;17:675–80.

    Article  PubMed  CAS  Google Scholar 

  50. Brown JH, Vites NP, Testa HJ, Prescott MC, Hunt LP, Gokal R, et al. Value of thallium myocardial imaging in the prediction of future cardiovascular events in patients with end-stage renal failure. Nephrol Dial Transplant 1993;8:433–7.

    PubMed  CAS  Google Scholar 

  51. Hase H, Joki N, Ishikawa H, Fukuda H, Imamura Y, Saijyo T, et al. Prognostic value of stress myocardial perfusion imaging using adenosine triphosphate at the beginning of haemodialysis treatment in patients with end-stage renal disease. Nephrol Dial Transplant 2004;19:1161–7.

    Article  PubMed  Google Scholar 

  52. Nanasato M, Hirayama H, Ando A, Isobe S, Nonokawa M, Kinoshita Y, et al. Incremental predictive value of myocardial scintigraphy with123I-BMIPP in patients with acute myocardial infarction treated with primary percutaneous coronary intervention. Eur J Nucl Med Mol Imaging 2004;31:1512–21.

    Article  PubMed  Google Scholar 

  53. Chikamori T, Fujita H, Nanasato M, Toba M, Nishimura T. Prognostic value of I-123 15-(p-iodophenyl)-3-(R,S) methylpentadecanoic acid myocardial imaging in patients with known or suspected coronary artery disease. J Nucl Cardiol 2005;12:172–8.

    Article  PubMed  Google Scholar 

  54. Matsuki T, Nagara T, Nakata T, Doi A, Takahashi H, Iwata M, et al. Prognostic value of fatty acid imaging in patients with angina pectoris without prior myocardial infarction: Comparison with stress thallium imaging. Eur J Nucl Med Mol Imaging 2004;31:1585–91.

    Article  PubMed  Google Scholar 

  55. Nishimura M, Tsukamoto K, Hasebe N, Tamaki N, Kikuchi K, Ono T. Prediction of cardiac death in hemodialysis patients by myocardial fatty acid imaging. J Am Coll Cardiol 2008;51:139–45.

    Article  PubMed  CAS  Google Scholar 

  56. Kudoh T, Tadamura E, Tamaki N, Hattori N, Inubushi M, Kubo S, et al. Iodinated free fatty acid and 201Tl uptake in chronically hypoperfused myocardium: Histologic correlation study. J Nucl Med 2000;41:293–6.

    PubMed  CAS  Google Scholar 

  57. Tamaki N, Tadamura E, Kawamoto M, Magata Y, Yonekura Y, Fujibayashi Y, et al. Decreased uptake of iodinated branched fatty acid analog indicates metabolic alterations in ischemic myocardium. J Nucl Med 1995;36:1974–80.

    PubMed  CAS  Google Scholar 

  58. Nakajima K, Shimizu K, Taki J, Uetani Y, Konishi S, Tonami N, et al. Utility of iodine-123-BMIPP in the diagnosis and follow-up of vasospastic angina. J Nucl Med 1995;36:1934–40.

    PubMed  CAS  Google Scholar 

  59. Takeishi Y, Sukekawa H, Saito H, Nishimura S, Shibu T, Sasaki Y, et al. Clinical significance of decreased myocardial uptake of 123I-BMIPP in patients with stable angina pectoris. Nucl Med Commun 1995;16:1002–8.

    Article  PubMed  CAS  Google Scholar 

  60. le Feuvre C, Dambrin G, Helft G, Beygui F, Touam M, Grünfeld JP, et al. Clinical outcome following angioplasty in dialysis patients: a case-control study in the era of coronary stenting. Heart 2001;85:556–60.

    Article  PubMed  Google Scholar 

  61. Hemmelgarn BR, Ghali WA, Quan H, Brant R, Norris CM, Taub KJ, et al. Poor long-term survival after coronary angiography in patients with renal insufficiency. Am J Kidney Dis 2001;37:64–72.

    Article  PubMed  CAS  Google Scholar 

  62. Ting HH, Tahirkheli NK, Berger PB, McCarthy JT, Timimi FK, Mathew V, et al. Evaluation of long-term survival after successful percutaneous coronary intervention among patients with chronic renal failure. Am J Cardiol 2001;87:630–3.

    Article  PubMed  CAS  Google Scholar 

  63. Nishimura M, Tokoro T, Nishida M, Hashimoto T, Kobayashi H, Yamazaki S, et al. Association of insulin resistance with de novo coronary stenosis after percutaneous coronary artery intervention in hemodialysis patients. Nephron Clin Nephrol 2008;109:c9–17.

    Article  CAS  Google Scholar 

  64. Hemmelgarn BR, Southern D, Culleton BF, Mitchell LB, Knudtson ML, Ghali WA, for the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease. (APPROACH) Investigators. Survival after coronary revascularization among patients with kidney disease. Circulation 2004;110:1890–5.

    Article  PubMed  Google Scholar 

  65. Herzog CA, Ma JZ, Collins AJ. Comparative survival of dialysis patients in the United States after coronary angioplasty, coronary artery stenting, and coronary artery bypass surgery and impact of diabetes. Circulation 2002;106:2207–11.

    Article  PubMed  Google Scholar 

  66. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 2002;346:1773–80.

    Article  PubMed  CAS  Google Scholar 

  67. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315–23.

    Article  PubMed  CAS  Google Scholar 

  68. Hassani S-E, Chu WW, Wolfram RM, Kuchulakanti PK, Xue Z, Gevorkian N, et al. Clinical outcome after percutaneous coronary intervention with drug-eluting stents in dialysis patients. J Invasive Cardiol 2006;18:273–7.

    PubMed  Google Scholar 

  69. Ishio N, Kobayashi Y, Takebayashi H, Iijima Y, Kanda J, Nakayama T, et al. Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients. Circ J 2007;71:1525–99.

    Article  PubMed  Google Scholar 

  70. Nishimura M, Tokoro T, Nishida M, Hashimoto T, Kobayashi H, Yamazaki S, et al. Myocardial fatty acid imaging identifies a group of hemodialysis patients at high risk for cardiac death after coronary revascularization. Kidney Int 2008;74:513–20.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. From the Cardiovascular Division, Division of Urology, Toujinkai Hospital, Kyoto, Japan

    Masato Nishimura MD & Toshihiko Ono MD

Authors
  1. Masato Nishimura MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Toshihiko Ono MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masato Nishimura MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nishimura, M., Ono, T. Clinical utility of myocardial fatty acid imaging in patients with end-stage renal disease. J Nucl Cardiol 15, 830–837 (2008). https://doi.org/10.1007/BF03007365

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03007365

Key Words

Search

Navigation